Authors: ZACHARIAE H ABRAMS B BLEEHEN SS BRAUTIGAM M BURROWS D ETTELT MJ FRY L HAPPLE R HAUSTEIN UF GANSLANDT J JUNG EG KNOP J KUHNE KH MELLEIN B MORK NJ ROGERS S SCHMIDT AG SCHOPF RE SUMNER M TAUBE KM WEIDINGER G WURDEL C ZAHN E

Citation: H. Zachariae et al., CONVERSION OF PSORIASIS PATIENTS FROM THE CONVENTIONAL FORMULATION OFCYCLOSPORINE-A TO A NEW MICROEMULSION FORMULATION - A RANDOMIZED, OPEN, MULTICENTER ASSESSMENT OF SAFETY AND TOLERABILITY, Dermatology, 196(2), 1998, pp. 231-236

Authors: KOO J ABRAMS B ALBRECHT G ALTMEYER P BAHMER FA BELAICH S BERTHJONES J BJERKE JR BOS JD BRAATHEN L BURG G BURROWS D CLAUDY A DRAKE LA DUBERTRET L ENGST R ETTELT MI FRENK E FROSCH PJ GANSLANDT J GOOS M GRAHAMBROWN RAC GUILHOU JJ HAUSTEIN UF HELLAND S HUTCHINSON K JACOBI H JUNG EG KANG S KIND P KNOP J LOWE NJ LUGER T MAHRLE G MARKS R MEFFERT H MEYER J MORK NJ MROWIETZ U NEUMANN HAM OLSEN EA ROGERS S RUZICKA T SCHMIDT AG SCHOPF E SHUPACK JL STARINK TM TIO D VANVLOTEN WA VERMEER BJ WOLLINA U

Citation: J. Koo et al., A RANDOMIZED, DOUBLE-BLIND-STUDY COMPARING THE EFFICACY, SAFETY AND OPTIMAL DOSE OF 2 FORMULATIONS OF CYCLOSPORINE, NEORAL AND SANDIMMUN, IN PATIENTS WITH SEVERE PSORIASIS, British journal of dermatology, 139(1), 1998, pp. 88-95